Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (6)
Type
(
2 selected
)
Type
Guidance (1648)
NICE advice (330)
Quality standard (200)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (219)
COVID-19 rapid guidelines (6)
Diagnostics guidance (40)
Highly specialised technologies guidance (20)
Interventional procedures guidance (563)
Medical technologies guidance (62)
Medicines practice guidelines (5)
NICE guidelines (338)
Public health guidelines (62)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (625)
Apply filters
Showing 1 to 10 of 1848
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA815
10 August 2022
10 August 2022
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer
TA816
10 August 2022
10 August 2022
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence
TA817
10 August 2022
10 August 2022
SecurAcath for securing percutaneous catheters
MTG34
5 June 2017
10 August 2022
Tobacco: preventing uptake, promoting quitting and treating dependence
NG209
30 November 2021
4 August 2022
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors
TA813
3 August 2022
3 August 2022
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis
TA814
3 August 2022
3 August 2022
Bioresorbable stent implantation to treat coronary artery disease
IPG732
3 August 2022
3 August 2022
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection
IPG733
3 August 2022
3 August 2022
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer
TA812
3 August 2022
3 August 2022
Current page
1
2
3
…
185
Page
1
of
185
Next page
Results per page
10
25
50
All